Italia markets closed
  • FTSE MIB

    22.848,58
    -214,97 (-0,93%)
     
  • Dow Jones

    30.932,37
    -469,64 (-1,50%)
     
  • Nasdaq

    13.192,35
    +72,92 (+0,56%)
     
  • Nikkei 225

    28.966,01
    -1.202,26 (-3,99%)
     
  • Petrolio

    61,66
    -1,87 (-2,94%)
     
  • BTC-EUR

    36.860,41
    -3.098,40 (-7,75%)
     
  • CMC Crypto 200

    912,88
    -20,25 (-2,17%)
     
  • Oro

    1.733,00
    -42,40 (-2,39%)
     
  • EUR/USD

    1,2088
    -0,0099 (-0,81%)
     
  • S&P 500

    3.811,15
    -18,19 (-0,48%)
     
  • HANG SENG

    28.980,21
    -1.093,96 (-3,64%)
     
  • Euro Stoxx 50

    3.636,44
    -48,84 (-1,33%)
     
  • EUR/GBP

    0,8667
    -0,0026 (-0,30%)
     
  • EUR/CHF

    1,0965
    -0,0048 (-0,43%)
     
  • EUR/CAD

    1,5380
    +0,0036 (+0,24%)
     

Intra-cellular Therapies Inc (ITCI) Chairman, President & CEO Sharon Mates Sold $1. ...

GuruFocus.com
·2 minuto per la lettura

- By insider

Chairman, President & CEO of Intra-cellular Therapies Inc (30-Year Financial, Insider Trades) Sharon Mates (insider trades) sold 27,847 shares of ITCI on 02/19/2021 at an average price of $39.23 a share. The total sale was $1.1 million.


Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders. Intra-Cellular Therapies Inc has a market cap of $2.87 billion; its shares were traded at around $35.860000 with and P/S ratio of 234.38. GuruFocus has detected 4 severe warning signs with Intra-Cellular Therapies Inc. .

CEO Recent Trades:

  • Chairman, President & CEO Sharon Mates sold 27,847 shares of ITCI stock on 02/19/2021 at the average price of $39.23. The price of the stock has decreased by 8.59% since.

CFO Recent Trades:

  • SVP of Finance CFO Lawrence J. Hineline sold 10,442 shares of ITCI stock on 02/19/2021 at the average price of $39.23. The price of the stock has decreased by 8.59% since.

Directors and Officers Recent Trades:

  • Chief Medical Officer Suresh K. Durgam sold 2,734 shares of ITCI stock on 02/19/2021 at the average price of $39.25. The price of the stock has decreased by 8.64% since.

  • EVP, Chief Commercial Officer Mark Neumann sold 5,184 shares of ITCI stock on 02/19/2021 at the average price of $39.22. The price of the stock has decreased by 8.57% since.

  • EVP and General Counsel Michael Halstead sold 11,139 shares of ITCI stock on 02/19/2021 at the average price of $39.24. The price of the stock has decreased by 8.61% since.

For the complete insider trading history of ITCI, click here

.This article first appeared on GuruFocus.